Split structural models for belief. by Abigail A. Lee (19935335)

Forest plot of the scaling exponent of hepatitis incidence from 2004 to 2023 (a. forest plot of hepatitis A; b. forest plot of hepatitis B; c. forest plot of hepatitis C; d. forest... by Ming Xue (591840)

Graphs showing the mean temperature increase at the positions with the highest mean temperature increase for the MIPS (A) and MONO (B) systems and three drilling protocols (DP1, DP... by Marsel Ganeyev (21453399)

Impact of B₄C & Fly ash on the Density of AMCs. by Charles Sarala Rubi (21608723)

“…There exists a good agreement between them.</p><p>Discussion</p><p>The research on LM6/B₄C/fly ash composite fabrication using Grey Relational Analysis (GRA) has significantly contributed to the development of high-performance materials for wear-related applications. …”

Effect of B₄C& Fly ash on the hardness of AMCs. by Charles Sarala Rubi (21608723)

“…There exists a good agreement between them.</p><p>Discussion</p><p>The research on LM6/B₄C/fly ash composite fabrication using Grey Relational Analysis (GRA) has significantly contributed to the development of high-performance materials for wear-related applications. …”

Variables for the bromeliad agent representing a single <i>T. utriculata</i> rosette. by Alexandra M. Campbell (3284094)

NMR aperture distribution of samples before and after 100 FTCs under three curing conditions: (a) standard curing; (b) 5 °C curing; (c) −3 °C curing. by YongHe Liu (20477123)

<i>In vitro</i> characterization of the mnuA::Tn and 0690::Tn mutants. by Aga E. Gelgie (17661720)

African catfish intervention sites, snail sampling sites and local primary schools in Chifunfu (A), Kahumulo (B) and Sweya (C). by Roland Proud (11764892)

Measurement of inflammatory cytokines in liver and heart tissues. by Ayça Toprak-Semiz (22582110)

Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of adult winter worker bees in the laboratory inoculated with A. <i>M. plutonius</i> ATCC3511 or B. <i>M. plutonius</i> 20... by Midhun Sebastian Jose (19336846)

Histopathological appearance of the liver. by Ayça Toprak-Semiz (22582110)

Histopathological appearance of the heart. by Ayça Toprak-Semiz (22582110)

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

VEGF-A121, VEGF-A165, and VEGF-A contents per unit platelets. by Masashi Okawa (8951294)

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

“…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …”

The effect of CRNN downregulation on migration and invasion ability in cSCC cells. by Changji Li (4806930)